Current role of radionuclide imaging in differentiated thyroid cancer

Nuclear medicine plays an integral role in the management of differentiated thyroid cancer. This editorial aims to provide a summary of the current role of radionuclide imaging, including whole body iodine scan and fluorodeoxyglucose (FDG)-positron emission tomography (PET), in the diagnostic work-u...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, K.T., Choi, Frankie P.T., Lee, Yolanda Y.P., Ahuja, Anil T.
Formato: Texto
Lenguaje:English
Publicado: e-Med 2008
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556502/
https://www.ncbi.nlm.nih.gov/pubmed/18818134
http://dx.doi.org/10.1102/1470-7330.2008.0024
Descripción
Sumario:Nuclear medicine plays an integral role in the management of differentiated thyroid cancer. This editorial aims to provide a summary of the current role of radionuclide imaging, including whole body iodine scan and fluorodeoxyglucose (FDG)-positron emission tomography (PET), in the diagnostic work-up and follow-up of patients with thyroid cancer.

Ejemplares similares